Treating Alopecia Areata: Where are we at the end of 2020?
Treating Alopecia Areata: Where are we at the end of 2020? Anthony Gilding, Science and Research Communication at CANAAF Alopecia Areata
Long Term use of JAK Inhibitors (CTP-543) Shows Promising Results In CoNCERT Pharmaceuticals Study
Long Term use of JAK Inhibitors (CTP-543) Shows Promising Results In CoNCERT Pharmaceuticals Study Anthony Gilding, Science Communication at CANAAF CANAAF
Burden of Illness in Alopecia Areata: A Cross-Sectional Online Survey Study
Alopecia Areata is a particularly distressing condition. The hair loss faced by patients is unexpected, and often rapid, leaving them feeling hopeless